Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Orion Oyj    ORNBV   FI0009014377

ORION OYJ (ORNBV)
Mes dernières consult.
Most popular
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Helsinki Ltd.
10/10/2017 10/11/2017 10/12/2017 10/13/2017 10/16/2017 Date
38.83(c) 38.73(c) 38.54(c) 37.89(c) 38.05(c) Last
385 163 364 165 459 986 445 180 234 092 Volume
-0.67% -0.26% -0.49% -1.69% +0.42% Change
More quotes
Financials (€)
Sales 2017 1 105 M
EBIT 2017 294 M
Net income 2017 204 M
Finance 2017 75,2 M
Yield 2017 3,80%
Sales 2018 1 156 M
EBIT 2018 311 M
Net income 2018 248 M
Finance 2018 104 M
Yield 2018 3,97%
P/E ratio 2017 23,12
P/E ratio 2018 21,66
EV / Sales2017 4,78x
EV / Sales2018 4,54x
Capitalization 5 356 M
More Financials
Company
Orion Oyj engages in the development of pharmaceutical and diagnostic test.It develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests.Its pharmaceutical research and development focuses on central nervous system drugs,... 
Sector
Pharmaceuticals
Calendar
10/26Earnings Release
More about the company
Surperformance© ratings of Orion Oyj
Trading Rating : Investor Rating :
More Ratings
Latest news on ORION OYJ
10/12 ORION OYJ : Publishing of Orion Corporation's Interim Report for January-Septemb..
10/05 ORION OYJ : receives Lean Prize 2016
09/22 ORION OYJ : Pharma scientists led research group wins award for study paper on d..
08/18 ORION CORPORATION : Managers' transactions - Heikki Westerlund
08/01 ORION OYJ : 146,000 Orion Corporation A shares converted into B shares
07/19 ORION OYJ : Group Half-Year Financial Report January-June 2017
07/19 ORION OYJ : Corporation's financial reporting and Annual General Meeting in 2018
07/14ORION OYJ : half-yearly earnings release
07/05 ORION OYJ : Publishing of Orion Corporation's Half-Yearly Report for January-Jun..
06/19 ORION OYJ : 187,133 Orion Corporation A shares converted into B shares
More news
Sector news : Pharmaceuticals - NEC
10/16DJALLERGAN : Loses Patent Fight in Federal Court
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 Miners provide foundation for FTSE while ConvaTec plummets
10/16 ASTRAZENECA : Pharma and medtech industries prepare for hard Brexit
10/16 CONVATEC : slashes revenue growth outlook, shares slump
More sector news : Pharmaceuticals - NEC
Latest Tweets
10/16Orion Engineered Carbons S.A's buy rating reiterated at KeyCorp. $25.00 PT.  
10/16Kevin Wilson has just been hired as exec VP, distribution at the recently re-..
5
10/15Fall foliage at NWS Seattle sharply contrasts the winter constellations retur..
5
10/14Susquehanna International Group LLP Buys Shares of 32,500 Orion Engineered Ca.. 
10/14Lewis Harknett is our first winner of the weekend from Orion Harriers! Congra..
1
More tweets
Qtime:138
News from SeekingAlpha
05/23 Orion Corporation (ORINF) Investor Presentation - Slideshow
05/23 Orion Corporation (ORINF) Investor Presentation - Slideshow
Chart ORION OYJ
Duration : Period :
Orion Oyj Technical Analysis Chart | ORNBV | FI0009014377 | 4-Traders
Technical analysis trends ORION OYJ
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Average target price 43,5 €
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Timo Antero Lappalainen President & Chief Executive Officer
Heikki Seppo Westerlund Chairman
Jari Karlson CFO, SVP-Animal Health & IR Contact
Christer Nordstedt Senior Vice President-Research & Development
Sirpa Tuulikki Jalkanen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORION OYJ-10.40%6 330
JOHNSON & JOHNSON18.42%366 178
NOVARTIS13.23%225 160
ROCHE HOLDING LTD.5.20%216 764
PFIZER11.88%216 409
MERCK AND COMPANY7.68%172 887